Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Raphael Pharmaceutical Inc fell by 58.00k. Cash Flow from Financing totalled 1.15m or -- of revenues. In addition the company used 1.20m for operations while cash from investing was breakeven.
Cash flow per share | -0.0335 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0155 |
---|---|
Tangible book value per share | -0.0155 |
More ▼
Balance sheet in USDView more
Current ratio | 0.3014 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼